XML 38 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements and Fair Values of Financial Instruments
12 Months Ended
Dec. 31, 2022
Fair Value Measurements and Fair Values of Financial Instruments [Abstract]  
Fair Value Measurements and Fair Values of Financial Instruments Note 18 - Fair Value Measurements and Fair Values of Financial Instruments

Management uses its best judgment in estimating the fair value of the Company’s financial instruments; however, there are inherent weaknesses in any estimation technique. Therefore, for substantially all financial instruments, the fair value estimates herein are not necessarily indicative of the amounts the Company could have realized in a sales transaction on the dates indicated. The estimated fair value amounts have been measured as of their respective year-ends and have not been re-evaluated or updated for purposes of these consolidated financial statements subsequent to those respective dates. As such, the estimated fair values of these financial instruments subsequent to the respective reporting dates may be different than the amounts reported at each year-end.

ASC Topic 820, Fair Value Measurements and Disclosures, establishes a fair value hierarchy that prioritizes the inputs to valuation methods used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

An asset’s or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.

For assets and liabilities measured at fair value on a recurring basis, the fair value measurements, by level, within the fair value hierarchy are as follows:

  

(Level 1)

  

(Level 2)

  

Quoted Prices in

Significant

(Level 3)

Active Markets

Other

Significant

for Identical

Observable

Unobservable

Description

Total

Assets

Inputs

Inputs

(In Thousands)

As of December 31, 2022:

  

  

  

Securities Available for Sale

Debt Securities Available for Sale

$

91,715

$

-

$

91,715

$

-

Marketable Equities

17,686

  

17,686

  

-

  

-

Total Securities Available for Sale

$

109,401

$

17,686

$

91,715

$

-

As of December 31, 2021:

  

  

  

Securities Available for Sale

Debt Securities Available for Sale

$

85,186

$

-

$

85,186

$

-

Marketable Equities

25,187

25,187

-

-

Total Securities Available for Sale

$

110,373

$

25,187

$

85,186

$

-

For assets and liabilities measured at fair value on a nonrecurring basis, the fair value measurements by level within the fair value hierarchy are as follows:

  

(Level 1)

  

(Level 2)

  

Quoted Prices in

Significant

(Level 3)

Active Markets

Other

Significant

for Identical

Observable

Unobservable

Description

Total

Assets

Inputs

Inputs

(In Thousands)

As of December 31, 2022:

  

  

  

Impaired loans

$

5,587

  

$

-

  

$

-

  

$

5,587

Other real estate owned

$

75

$

-

$

-

$

75

As of December 31, 2021:

  

  

  

Impaired loans

$

14,796

  

$

-

  

$

-

  

$

14,796

Other real estate owned

$

75

$

-

$

-

$

75

Certain impaired loans were adjusted to the fair value, less costs to sell, of the underlying collateral securing these loans resulting in losses.  The loss is not recorded directly as an adjustment to current earnings, but rather as a component in determining the allowance for loan losses.  Fair value was measured using appraised values of collateral and adjusted as necessary by management based on unobservable inputs for specific properties.  Losses (recoveries) on impaired loans for the years ended December 31, 2022 and 2021 were ($5.0) million and $5.7 million respectively.   

The following table presents additional quantitative information about assets measured at fair value on a nonrecurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value, (Dollars in thousands):

Quantitative Information about Level 3 Fair Value Measurements

Fair Value

Valuation

Unobservable

Range

Estimate

Techniques

Input

December 31, 2022:

Impaired Loans

$

5,587

Appraisal of collateral (1)

Appraisal adjustments (2)

0%-10%

Other Real Estate Owned

$

75

Appraisal of collateral (1)

Appraisal adjustments (2)

0%-10%

Note 18- Fair Value Measurements and Fair Value of Financial Instruments (continued)

Quantitative Information about Level 3 Fair Value Measurements

Fair Value

Valuation

Unobservable

Range

Estimate

Techniques

Input

December 31, 2021:

Impaired Loans

$

14,796

Appraisal of collateral (1)

Appraisal adjustments (2)

0%-10%

Other Real Estate Owned

$

75

Appraisal of collateral (1)

Appraisal adjustments (2)

0%-10%

(1)Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various level 3 inputs which are not identifiable.

(2)Appraisals may be adjusted by management for qualitative factors such as age of appraisal, expected condition of property, economic conditions, and estimated liquidation expenses. The range of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.

The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments at December 31, 2022 and 2021:

Cash and Cash Equivalents (Carried at Cost)

The carrying amounts reported in the consolidated statements of financial condition for cash and interest-earning deposits approximate those assets’ fair values.

Securities (Carried at Fair Value)

The fair value of securities is determined by obtaining quoted market prices on nationally recognized securities exchanges (Level 1), or matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted prices.

Loans Held for Sale (Carried at Cost)

The fair value of loans held for sale is determined, when possible, using quoted secondary-market prices. If no such quoted prices exist, the fair value of a loan is determined using quoted prices for a similar loan or loans, adjusted for specific attributes of that loan. Loans held for sale are carried at the lower of cost or fair value.

Loans Receivable (Carried at Cost)

The fair values of loans, except for certain impaired loans, are estimated using discounted cash flow analyses, using market rates at the date of the Statement of Financial Condition that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values.

Impaired Loans (Generally Carried at Fair Value)

Impaired loans are those for which the Company has measured and recorded an impairment generally based on the fair value of the loan’s collateral, less estimated costs to sell. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the expected proceeds. These assets are included as Level 3 fair values, based upon the lowest level of input that is significant to the fair value measurements. The fair value at December 31, 2022 and 2021 consists of the loan balances of $8,371,000 and $22,624,000 net of a valuation allowance of $2,784,000 and $7,828,000, respectively.

FHLB of New York Stock (Carried at Cost)

The carrying amount of restricted investment in bank stock approximates fair value, and considers the limited marketability of such securities.

Accrued Interest Receivable and Payable (Carried at Cost)

The carrying amount of accrued interest receivable and accrued interest payable approximates its fair value.

Deposits (Carried at Cost)

The fair values disclosed for demand deposits (e.g., interest and non-interest checking, passbook savings and money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits.

Debt Including Subordinated Debentures (Carried at Cost)

Fair values of debt are estimated using discounted cash flow analysis, based on quoted prices for new long-term debt with similar credit risk characteristics, terms and remaining maturity. These prices obtained from this active market represent a market value that is deemed to represent the transfer price if the liability were assumed by a third party.

Note 18- Fair Value Measurements and Fair Value of Financial Instruments (continued)

Off-Balance Sheet Financial Instruments (Disclosed at Cost)

Fair values for the Bank’s off-balance sheet financial instruments (lending commitments and unused lines of credit) are based on fees currently charged in the market to enter into similar agreements, taking into account, the remaining terms of the agreements and the counterparties’ credit standing. The fair value of these commitments was deemed immaterial and is not presented in the accompanying table.

The carrying values and estimated fair values of financial instruments were as follows at December 31, 2022 and 2021:

As of December 31, 2022

Quoted Prices in Active

Significant

Significant

Carrying

Markets for Identical Assets

Other Observable Inputs

Unobservable Inputs

Value

Fair Value

(Level 1)

(Level 2)

(Level 3)

(In Thousands)

Financial assets:

  

  

  

Cash and cash equivalents

$

229,359 

$

229,359 

  

$

229,359 

  

$

-

$

-

Interest-earning time deposits

735 

735 

  

-

  

735 

-

Debt securities available for sale

91,715 

91,715 

  

-

  

91,715 

-

Equity investments

17,686 

17,686 

17,686 

-

-

Loans held for sale

658 

658 

  

-

  

658 

-

Loans receivable, net

3,045,331 

2,876,925 

  

-

  

-

2,876,925 

FHLB of New York stock, at cost

20,113 

20,113 

  

-

  

20,113 

-

Accrued interest receivable

13,455 

13,455 

  

-

  

13,455 

-

Financial liabilities:

  

  

Deposits

2,811,607 

2,499,978 

  

1,713,754 

  

786,224 

-

Debt

382,261 

377,227 

  

-

  

377,227 

-

Subordinated debentures

37,508 

40,113 

-

40,113 

-

Accrued interest payable

3,073 

3,073 

  

-

  

3,073 

-

As of December 31, 2021

Quoted Prices in Active

Significant

Significant

Carrying

Markets for Identical Assets

Other Observable Inputs

Unobservable Inputs

Value

Fair Value

(Level 1)

(Level 2)

(Level 3)

(In Thousands)

Financial assets:

  

  

  

Cash and cash equivalents

$

411,629 

$

411,629 

  

$

411,629 

  

$

-

$

-

Interest-earning time deposits

735 

735 

  

-

  

735 

-

Debt securities available for sale

85,186 

85,186 

  

-

  

85,186 

-

Equity investments

25,187 

25,187 

25,187 

-

-

Loans held for sale

952 

952 

  

-

  

952 

-

Loans receivable, net

2,304,942 

2,313,204 

  

-

  

-

2,313,204 

FHLB of New York stock, at cost

6,084 

6,084 

  

-

  

6,084 

-

Accrued interest receivable

9,183 

9,183 

  

-

  

9,183 

-

Financial liabilities:

  

  

Deposits

2,561,402 

2,520,191 

  

1,881,121 

  

639,070 

-

Debt

71,711 

71,214 

  

-

  

71,214 

-

Subordinated debentures

37,275 

45,020 

-

45,020 

-

Accrued interest payable

1,051 

1,051 

  

-

  

1,051 

-

+